Oral Treatment for Mycobacterium ulcerans Infection: Results From a Pilot Study in Benin
Open Access
- 1 January 2011
- journal article
- research article
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 52 (1) , 94-96
- https://doi.org/10.1093/cid/ciq072
Abstract
Mycobacterium ulcerans infection is responsible for severe skin lesions in sub-Saharan Africa. We enrolled 30 Beninese patients with Buruli ulcers in a pilot study to evaluate efficacy of an oral chemotherapy using rifampicin plus clarithromycin during an 8-week period. The treatment was well tolerated, and all patients were healed by 12 months after initiation of therapy without relapse.This publication has 12 references indexed in Scilit:
- Antimicrobial treatment for early, limited Mycobacterium ulcerans infection: a randomised controlled trialThe Lancet, 2010
- Management of Mycobacterium ulcerans infection in a pregnant woman in Benin using rifampicin and clarithromycinThe Medical Journal of Australia, 2008
- Bactericidal and Sterilizing Activities of Several Orally Administered Combined Regimens against Mycobacterium ulcerans in MiceAntimicrobial Agents and Chemotherapy, 2008
- Promising Clinical Efficacy of Streptomycin-Rifampin Combination for Treatment of Buruli Ulcer ( Mycobacterium ulcerans Disease)Antimicrobial Agents and Chemotherapy, 2007
- Development of Highly Organized Lymphoid Structures in Buruli Ulcer Lesions after Treatment with Rifampicin and StreptomycinPLoS Neglected Tropical Diseases, 2007
- Orally Administered Combined Regimens for Treatment of Mycobacterium ulcerans Infection in MiceAntimicrobial Agents and Chemotherapy, 2007
- Outcomes for Mycobacterium ulcerans infection with combined surgery and antibiotic therapy: findings from a south‐eastern Australian case seriesThe Medical Journal of Australia, 2007
- Buruli ulcer: emerging from obscurityThe Lancet, 2006
- Efficacy of the Combination Rifampin-Streptomycin in Preventing Growth of Mycobacterium ulcerans in Early Lesions of Buruli Ulcer in HumansAntimicrobial Agents and Chemotherapy, 2005
- Toxic effects and drug interactions of antimycobacterial therapyClinics in Dermatology, 1995